Posted by Michael Wonder on 24 May 2022
Thousands of people in England could benefit after NICE recommends treatment option for two forms of sight loss
24 May 2022 - NICE recommends faricimab as treatment option for adults with wet age-related macular degeneration or diabetic macular oedema.
Thousands of people in England could benefit after NICE today published final draft guidance recommending a new drug to help treat two leading causes of sight loss and visual impairment.
